Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SL Pathology Leasing of Texas
AddedMar 20, 2024
UpdatedJun 18, 2026
SL Pathology Leasing of Texas

SL Pathology Leasing of Texas

Texas healthcare provider since 2009. Operating in Bellaire, TX.

HQ
Bellaire, TX, US
Founded
2009
Overview
Compare
Fundraising
Employees

SL Pathology Leasing of Texas, LLC operates in the health care sector.

The company was incorporated in 2009 and is based in Bellaire, Texas.

SL Pathology Leasing of Texas - Similar Companies

PathGroup logo

PathGroup

Greater Alabama Lithotripsy logo

Greater Alabama Lithotripsy

Texas Health Resources logo

Texas Health Resources

texashealth.org

BetenHealth logo

BetenHealth

Tesis Labs logo

Tesis Labs

Cblpath logo

Cblpath

cblpath.com

Turek Labs logo

Turek Labs

Thermaleve logo

Thermaleve

Fresh Coast Lithotripsy logo

Fresh Coast Lithotripsy

Ad Path Labs logo

Ad Path Labs

rebiz.com

Gulf States Cryotherapy logo

Gulf States Cryotherapy

Livingston Med Lab logo

Livingston Med Lab

ZetaRx Biosciences logo

ZetaRx Biosciences

Texas Medical Center logo

Texas Medical Center

Texas Neurology Consultants logo

Texas Neurology Consultants

SL Pathology Leasing of Texas - Quick Facts

Who are SL Pathology Leasing of Texas' competitors?

Companies similar to SL Pathology Leasing of Texas include PathGroup, Greater Alabama Lithotripsy, Texas Health Resources and BetenHealth.

When was SL Pathology Leasing of Texas founded?

SL Pathology Leasing of Texas was founded in 2009.

Where is SL Pathology Leasing of Texas' headquarters located?

SL Pathology Leasing of Texas' headquarters is located in Bellaire, TX, US.

When was SL Pathology Leasing of Texas' last funding round?

SL Pathology Leasing of Texas' most recent funding round was for $1.8M (USD) in February 2010.

How much has SL Pathology Leasing of Texas raised to-date?

As of Feb 11, 2010, SL Pathology Leasing of Texas has raised a total of $1.8M (USD).

How many employees does SL Pathology Leasing of Texas have?

SL Pathology Leasing of Texas has 5 employees as of Feb 5, 2024.

SL Pathology Leasing of Texas - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Healthcare
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories